Literature DB >> 12809736

A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method.

Tatsuya Kishimoto1, Takeshi Matsuoka, Shigeyuki Imamura, Koji Mizuno.   

Abstract

BACKGROUND: Several methods for measuring concentrations of lysophosphatidic acid (LPA), a lipid mediator, have been reported to date. However, these methods are not routinely used because most of them require specialized instrument and a complicated protocol.
METHODS: We developed a novel LPA assay using enzymatic cycling. LPA in a sample is hydrolyzed with lysophospholipase to glycerol-3-phosphate, followed by enzymatic cycling using glycerol-3-phosphate oxidase and glycerol-3-phosphate dehydrogenase. Amplified concentrations of hydrogen peroxides, a product of the enzymatic cycling, are then colorimetrically measured.
RESULTS: This method was specific for LPA, being insensitive to the presence of phosphatidic acid or lysophosphatidylcholine. The within-run and between-run CVs were 1.31-1.32% and 0.73-1.03%, respectively. The recoveries of exogenous LPA added to plasma were 100.3-101.6%. In males, LPA concentrations (mean+/-S.D.) of human serum and EDTA-plasma were 0.41+/-0.14 and 0.08+/-0.02 micromol/l, respectively. In females, they were 0.41+/-0.12 and 0.09+/-0.02 micromol/l, respectively.
CONCLUSIONS: This novel colorimetric assay for determination of LPA using enzymatic cycling is simple and highly sensitive. It can be used with an automatic analyzer. It may also be useful for further studies of the biological functions of LPA as well as clinical applications in various disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809736     DOI: 10.1016/s0009-8981(03)00165-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  15 in total

1.  Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.

Authors:  Makoto Kurano; Kuniyuki Kano; Tomotaka Dohi; Hirotaka Matsumoto; Koji Igarashi; Masako Nishikawa; Ryunosuke Ohkawa; Hitoshi Ikeda; Katsumi Miyauchi; Hiroyuki Daida; Junken Aoki; Yutaka Yatomi
Journal:  J Lipid Res       Date:  2016-12-22       Impact factor: 5.922

2.  Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA).

Authors:  Sangderk Lee; Kevin R Lynch
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

3.  An ultrasensitive enzymatic method for measuring mevalonic acid in serum.

Authors:  Takeshi Matsuoka; Shigeru Ueda; Hideyuki Matsumoto; Masanobu Kawakami
Journal:  J Lipid Res       Date:  2012-06-19       Impact factor: 5.922

4.  Autotaxin regulates vascular development via multiple lysophosphatidic acid (LPA) receptors in zebrafish.

Authors:  Hiroshi Yukiura; Kotaro Hama; Keita Nakanaga; Masayuki Tanaka; Yoichi Asaoka; Shinichi Okudaira; Naoaki Arima; Asuka Inoue; Takafumi Hashimoto; Hiroyuki Arai; Atsuo Kawahara; Hiroshi Nishina; Junken Aoki
Journal:  J Biol Chem       Date:  2011-10-04       Impact factor: 5.157

Review 5.  Roles of lysophosphatidic acid in cardiovascular physiology and disease.

Authors:  Susan S Smyth; Hsin-Yuan Cheng; Sumitra Miriyala; Manikandan Panchatcharam; Andrew J Morris
Journal:  Biochim Biophys Acta       Date:  2008-06-10

6.  Autotaxin through lysophosphatidic acid stimulates polarization, motility, and transendothelial migration of naive T cells.

Authors:  Yafeng Zhang; Yi-Chun Maria Chen; Matthew F Krummel; Steven D Rosen
Journal:  J Immunol       Date:  2012-09-07       Impact factor: 5.422

7.  Challenges in accurate quantitation of lysophosphatidic acids in human biofluids.

Authors:  Joelle M Onorato; Petia Shipkova; Anne Minnich; Anne-Françoise Aubry; John Easter; Adrienne Tymiak
Journal:  J Lipid Res       Date:  2014-05-28       Impact factor: 5.922

Review 8.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

9.  Structural basis for specific inhibition of Autotaxin by a DNA aptamer.

Authors:  Kazuki Kato; Hisako Ikeda; Shin Miyakawa; Satoshi Futakawa; Yosuke Nonaka; Masatoshi Fujiwara; Shinichi Okudaira; Kuniyuki Kano; Junken Aoki; Junko Morita; Ryuichiro Ishitani; Hiroshi Nishimasu; Yoshikazu Nakamura; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2016-04-04       Impact factor: 15.369

10.  Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Authors:  Lin Ma; Hitoshi Uchida; Jun Nagai; Makoto Inoue; Jerold Chun; Junken Aoki; Hiroshi Ueda
Journal:  Mol Pain       Date:  2009-11-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.